Oral synthetic phospholipid (DMPC) raises high-density lipoprotein cholesterol levels, improves high-density lipoprotein function, and markedly reduces atherosclerosis in apolipoprotein E-null mice

Circulation

Volumn 108, Issue 14, 2003, Pages 1735-1739

  Navab, Mohamad ^a   Hama, Susan ^b   Hough, Greg ^b   Fogelman, Alan M ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

Atherosclerosis; Lipids; Lipoproteins

Indexed keywords

APOLIPOPROTEIN E; DIMYRISTOYLPHOSPHATIDYLCHOLINE; DRINKING WATER; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHATIDYLCHOLINE; PHOSPHOLIPID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA INJURY; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL METABOLISM; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG METABOLISM; EGG; FEMALE; IN VIVO STUDY; JEJUNUM; LIPID TRANSPORT; LIPOPROTEIN SYNTHESIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REMISSION; SOYBEAN; STATISTICAL SIGNIFICANCE;

ADMINISTRATION, ORAL; ANIMALS; APOLIPOPROTEIN A-I; APOLIPOPROTEINS E; ARTERIOSCLEROSIS; CHEMOTAXIS; CHOLESTEROL, HDL; COCULTURE TECHNIQUES; DIMYRISTOYLPHOSPHATIDYLCHOLINE; FEMALE; LIPOPROTEINS, HDL; MALE; MICE; MICE, KNOCKOUT; MONOCYTES;

EID: 0141988863     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000089375.60050.35     Document Type: Article

References (24)

1. Huang W, Saski J, Matsunaga A, et al. A single amino acid deletion in the carboxy terminal of apolipoprotein A-I impairs lipid binding and cellular interaction. Arterioscler Thromb Vasc Biol. 2000;20:210-216.
2. O'Brien BC, Corrigan SM. Influence of dietary soybean and egg lecithins on lipid responses in cholesterol-fed guinea pigs. Lipids. 1988;23:1-14.
3. Wilson TA, Meservey CM, Nicolosi RJ. Soy lecithin reduces plasma lipoprotein cholesterol and early atherogenesis in hypercholesterolemic monkeys and hamsters: beyond linoleate. Atherosclerosis. 1998;140:147-153.
4. Jimenez MA, Scarino ML, Vignolini F, et al. Evidence that polyunsaturated lecithin induces a reduction in plasma cholesterol level and favorable changes in lipoprotein composition in hypercholesterolemic rats. J Nutr. 1990;120:659-667.
5. Navder KP, Baraona E, Leo MA, et al. Oxidation of LDL in baboons is increased by alcohol and attenuated by polyenylphosphatidylcholine. J Lipid Res. 1999;40:983-987.
6. Greten H, Raetzer H, Stiehl A, et al. The effect of polyunsaturated phosphatidylcholine on plasma lipids and fecal sterol excretion. Atherosclerosis. 1980;36:81-88.
7. Childs MT, Bowlin JA, Ogilvie JT, et al. The contrasting effects of a dietary soya lecithin product and corn oil on lipoprotein lipids in normolipidemic and familial hypercholesterolemic subjects. Atherosclerosis. 1981;38:217-228.
8. Vroulis G, Smith RC, Schoolar JC, et al. Reduction of cholesterol risk factors by lecithin in patients with Alzheimer's disease. Am J Psychiatry, 1982;139:1633-1634.
9. Brook JG, Linn S, Aviram M. Dietary soya lecithin decreases plasma triglyceride levels and inhibits collagen- and ADP-induced platelet aggregation. Biochem Med Metab Biol. 1986;35:31-39.
10. Kesaniemi YA, Grundy SM. Effects of dietary polyenylphosphatidylcholine on metabolism of cholesterol and triglycerides in hypertriglyceridemic patients. Am J Clin Nutr. 1986;43:98-107.
11. O'Brien BC, Andrews VG. Influence of dietary egg and soybean phospholipids and triacylglycerols on human serum lipoproteins. Lipids. 1993;28:7-12.
12. Wood JL, Allison RG. Effects of consumption of choline and lecithin on neurological and cardiovascular systems. Fed Proc. 1982;41:3015-3021.
13. Knuiman JT, Beynen AC, Katan MB. Lecithin intake and serum cholesterol. Am J Clin Nutr. 1989;49:266-268.
14. Wang H, Roberson R, Du J, et al. Regulation of apolipoprotein secretion by biliary lipids in newborn swine intestinal epithelial cells. Am J Physiol. 1999;276:G353-G362.
15. Wang H, Du J, Lu S, et al. Regulation of intestinal apolipoprotein A-I synthesis by dietary phosphatidylcholine in newborn swine. Lipids. 2001;36:683-687.
16. Navab M, Anantharamaiah GM, Hama S, et al. Oral administration of an apo A-I mimetic peptide synthesized from D-amino acids dramatically reduces atherosclerosis in mice independent of plasma cholesterol. Circulation. 2002;105:290-292.
17. Navab M, Hama SY, Hough GP, et al. A cell-free assay for detecting HDL that is dysfunctional in preventing the formation of or inactivating oxidized phospholipids. J Lipid Res. 2001;42:1308-1317.
18. Tangirala RK, Rubin E, Palinski W. Quantitation of atherosclerosis in murine models: correlation between lesions in the aortic origin and in the entire aorta, and differences in the extent of lesions between sexes in LDL receptor-deficient and apolipoprotein E-deficient mice. J Lipid Res. 1995;36:2320-2328.
19. Tangirala RK, Tsukamoto K, Chun S, et al. Regression of atherosclerosis induced by liver-directed gene transfer of apolipoprotein A-I in mice. Circulation. 1999;26:1816-1822.
20. Navab M, Hama SY, Cooke CJ, et al. Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: step 1. J Lipid Res. 2000;41:1481-1494.
21. Navab M, Hama SY, Anantharamaiah GM, et al. Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: steps 2 and 3. J Lipid Res. 2000;41:1495-1508.
22. Van Lenten BJ, Wagner AC, Anantharamaiah GM, et al. Influenza infection promotes macrophage traffic into arteries of mice that is prevented by D-4F, an apolipoprotein A-1 mimetic peptide. Circulation. 2002;106:1127-1132.
23. Escola-Gil JC, Julve J, Marzal-Casacuberta A, et al. Expression of human apolipoprotein A-II in apolipoprotein E-deficient mice induces features of familial combined hyperlipidemia. J Lipid Res. 2000;41:1328-1338.
24. Kummrow E, Hussain MM, Pan M, et al. Myristic acid increases dense lipoprotein secretion by inhibiting apoB degradation and triglyceride recruitment. J Lipid Res. 2002;43:2155-2163.